Keep an eye on: VRAL, LPJC, TPTX, OPSY, DLAD

VRAL released a PR that squashed the recent FDA rumor surrounding VRAL. "The company has not filed an IND with the FDA, and does not expect to do so within the month." Read the full PR here.